scholarly journals Design of a Silica-aerogel-based Cosmic Dust Collector for the Tanpopo Mission Aboard the International Space Station

Author(s):  
Makoto TABATA ◽  
Eiichi IMAI ◽  
Hajime YANO ◽  
Hirofumi HASHIMOTO ◽  
Hideyuki KAWAI ◽  
...  
2018 ◽  
Vol 2018 ◽  
pp. 1-7 ◽  
Author(s):  
T. V. Grebennikova ◽  
A. V. Syroeshkin ◽  
E. V. Shubralova ◽  
O. V. Eliseeva ◽  
L. V. Kostina ◽  
...  

Cosmic dust samples from the surface of the illuminator of the International Space Station (ISS) were collected by a crew member during his spacewalk. The sampler with tampon in a vacuum container was delivered to the Earth. Washouts from the tampon’s material and the tampon itself were analyzed for the presence of bacterial DNA by the method of nested PCR with primers specific to DNA of the genusMycobacteria, DNA of the strains of capsular bacteriaBacillus, and DNA encoding 16S ribosomal RNA. The results of amplification followed by sequencing and phylogenetic analysis indicated the presence of the bacteria of the genusMycobacteriaand the extreme bacterium of the genusDelftiain the samples of cosmic dust. It was shown that the DNA sequence of one of the bacteria of the genusMycobacteriawas genetically similar to that previously observed in superficial micro layer at the Barents and Kara seas’ coastal zones. The presence of the wild land and marine bacteria DNA on the ISS suggests their possible transfer from the stratosphere into the ionosphere with the ascending branch of the global electric circuit. Alternatively, the wild land and marine bacteria as well as the ISS bacteria may all have an ultimate space origin.


2005 ◽  
Author(s):  
Danielle Paige Smith ◽  
Vicky E. Byrne ◽  
Cynthia Hudy ◽  
Mihriban Whitmore

2020 ◽  
Vol 91 (1) ◽  
pp. 41-45 ◽  
Author(s):  
Virginia. E. Wotring ◽  
LaRona K. Smith

INTRODUCTION: There are knowledge gaps in spaceflight pharmacology with insufficient in-flight data to inform future planning. This effort directly addressed in-mission medication use and also informed open questions regarding spaceflight-associated changes in pharmacokinetics (PK) and/or pharmacodynamics (PD).METHODS: An iOS application was designed to collect medication use information relevant for research from volunteer astronaut crewmembers: medication name, dose, dosing frequency, indication, perceived efficacy, and side effects. Leveraging the limited medication choices aboard allowed a streamlined questionnaire. There were 24 subjects approved for participation.RESULTS: Six crewmembers completed flight data collection and five completed ground data collection before NASA’s early study discontinuation. There were 5766 medication use entries, averaging 20.6 ± 8.4 entries per subject per flight week. Types of medications and their indications were similar to previous reports, with sleep disturbances and muscle/joint pain as primary drivers. Two subjects treated prolonged skin problems. Subjects also used the application in unanticipated ways: to note drug tolerance testing or medication holiday per research protocols, and to share data with flight surgeons. Subjects also provided usability feedback on application design and implementation.DISCUSSION: The volume of data collected (20.6 ± 8.4 entries per subject per flight week) is much greater than was collected previously (<12 per person per entire mission), despite user criticisms regarding app usability. It seems likely that improvements in a software-based questionnaire application could result in a robust data collection tool that astronauts find more acceptable, while simultaneously providing researchers and clinicians with useful data.Wotring VE, Smith LK. Dose tracker application for collecting medication use data from International Space Station crew. Aerosp Med Hum Perform. 2020; 91(1):41–45.


2004 ◽  
Vol 10 (2-3) ◽  
pp. 81-86 ◽  
Author(s):  
S.I. Klimov ◽  
◽  
V.Ye. Korepanov ◽  

Sign in / Sign up

Export Citation Format

Share Document